A prospective study of predictors of adherence to combination antiretroviral medication

被引:340
作者
Golin, CE
Liu, HH
Hays, RD
Miller, LG
Beck, CK
Ickovics, J
Kaplan, AH
Wenger, NS
机构
[1] Univ N Carolina, Sheps Ctr Hlth Serv Res, Dept Hlth Behav & Hlth Educ, Chapel Hill, NC 27599 USA
[2] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[3] Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA
[4] Harbor UCLA Med Ctr, Div HIV Serv, Torrance, CA 90509 USA
[5] Yale Univ, Sch Publ Hlth, New Haven, CT USA
[6] Univ N Carolina, Dept Med, Chapel Hill, NC USA
[7] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
[8] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[9] Univ Calif Los Angeles, Ctr AIDS Res, Los Angeles, CA USA
[10] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA
关键词
adherence; antiretroviral; medication compliance; HIV;
D O I
10.1046/j.1525-1497.2002.11214.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVE: Adherence to complex antiretroviral therapy (ART) is critical for HIV treatment but difficult to achieve. The development of interventions to improve adherence requires detailed information regarding barriers to adherence. However, short follow-up and inadequate adherence measures have hampered such determinations. We sought to assess predictors of long-term (up to 1 year) adherence to newly initiated combination ART using an accurate, objective adherence measure. DESIGN: A prospective cohort study of 140 HIV-infected patients at a county hospital HIV clinic during the year following initiation of a new highly active ART regimen. MEASURES AND MAIN RESULTS: We measured adherence every 4 weeks, computing a composite score from electronic medication bottle caps, pill count and self-report. We evaluated patient demographic, biomedical, and psychosocial characteristics, features of the regimen, and relationship with one's HIV provider as predictors of adherence over 48 weeks. On average, subjects took 71% of prescribed doses with over 95% of patients achieving suboptimal (<95%) adherence. In multivariate analyses, African-American ethnicity, lower income and education, alcohol use, higher dose frequency, and fewer adherence aids (e.g., pillboxes, timers) were independently associated with worse adherence. After adjusting for demographic and clinical factors, those actively using drugs took 59% of doses versus 72% for nonusers, and those drinking alcohol took 66% of doses versus 74% for nondrinkers. Patients with more antiretroviral doses per day adhered less well. Participants using no adherence aids took 68% of doses versus 76% for those in the upper quartile of number of adherence aids used. CONCLUSIONS: Nearly all patients' adherence levels were suboptimal, demonstrating the critical need for programs to assist patients with medication taking. Interventions that assess and treat substance abuse and incorporate adherence aids may be particularly helpful and warrant further study.
引用
收藏
页码:756 / 765
页数:10
相关论文
共 80 条
[1]  
ANDERSON L A, 1990, Diabetes Care, V13, P66
[2]  
[Anonymous], 1993, Doctors Talking to Patients/Patients Talking to Doctors
[3]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[4]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[5]  
BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121
[6]   Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86
[7]   Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease [J].
Catz, SL ;
Kelly, JA ;
Bogart, LM ;
Benotsch, EG ;
McAuliffe, TL .
HEALTH PSYCHOLOGY, 2000, 19 (02) :124-133
[8]   Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments [J].
Chesney, MA ;
Ickovics, JR ;
Chambers, DB ;
Gifford, AL ;
Neidig, J ;
Zwickl, B ;
Wu, AW .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03) :255-266
[9]  
Chow R., 1993, Canadian Journal of Hospital Pharmacy, V46, P171
[10]   A GLOBAL MEASURE OF PERCEIVED STRESS [J].
COHEN, S ;
KAMARCK, T ;
MERMELSTEIN, R .
JOURNAL OF HEALTH AND SOCIAL BEHAVIOR, 1983, 24 (04) :385-396